[Rationality of performing hyperthermic intraperitoneal chemotherapy 5-8 weeks after primary tumor resection for patients with locally advanced colorectal cancer-based on COLOPEC].

MLA

Lei, Z. Y., et al. “[Rationality of Performing Hyperthermic Intraperitoneal Chemotherapy 5-8 Weeks after Primary Tumor Resection for Patients with Locally Advanced Colorectal Cancer-Based on COLOPEC].” Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery, vol. 22, no. 12, Dec. 2019, pp. 1115–17. EBSCOhost, https://doi.org/10.3760/cma.j.issn.1671-0274.2019.12.004.

APA

Lei, Z. Y., Guan, T. P., Luo, J. L., Tang, H. S., & Cui, S. Z. (2019). [Rationality of performing hyperthermic intraperitoneal chemotherapy 5-8 weeks after primary tumor resection for patients with locally advanced colorectal cancer-based on COLOPEC]. Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery, 22(12), 1115–1117. https://doi.org/10.3760/cma.j.issn.1671-0274.2019.12.004

Chicago

Lei, Z Y, T P Guan, J L Luo, H S Tang, and S Z Cui. 2019. “[Rationality of Performing Hyperthermic Intraperitoneal Chemotherapy 5-8 Weeks after Primary Tumor Resection for Patients with Locally Advanced Colorectal Cancer-Based on COLOPEC].” Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery 22 (12): 1115–17. doi:10.3760/cma.j.issn.1671-0274.2019.12.004.